Filing Details

Accession Number:
0001140361-16-049007
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-28 16:14:31
Reporting Period:
2016-01-26
Filing Date:
2016-01-28
Accepted Time:
2016-01-28 16:14:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021412 W Jack Schuler C/O Vermillion, Inc.
12117 Bee Caves Rd Bldg 3 Ste 100
Austin TX 78738
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2016-01-26 700 $1.60 2,154,896 No 4 P Indirect See footnote
Common Stock, Par Value $0.001 Per Share Acquisiton 2016-01-27 1,750 $1.59 2,156,646 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share 6,673,029 Direct
Footnotes
  1. The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.57 to $1.60. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  2. The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.58 to $1.60. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
  3. These shares of common stock are directly owned by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.